About The Study: The results of this study including 121,000 Singaporean children ages 1 through 4 suggest that completion of a primary mRNA vaccine series provided protection against SARS-CoV-2 infection. Although incidence of hospitalization and severe illness is low in this age group, there is potential benefit of vaccination in preventing infection and potential sequelae.
Authors: Liang En Wee, M.R.C.P., M.P.H., of the National Centre for Infectious Diseases in Singapore, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamapediatrics.2023.4505)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2023.4505?guestAccessKey=e5b9f91f-15c0-4856-9af7-ff5e27be397f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=101623
JAMA Pediatrics